Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

108.49
-1.6600-1.51%
Post-market: 108.540.1330+0.12%18:53 EDT
Volume:1.14M
Turnover:124.09M
Market Cap:26.08B
PE:-31.47
High:110.72
Open:110.50
Low:108.41
Close:110.15
Loading ...

Strategic Importance of BioNTech’s COVID-19 Vaccine and Oncology Ambitions Drive Buy Rating

TIPRANKS
·
07 May

BioNTech SE (BNTX) Gets a Buy from Evercore ISI

TIPRANKS
·
07 May

Stock Track | BioNTech Plummets 5.04% as Analysts Cut Price Targets Following Q1 Report

Stock Track
·
07 May

BioNTech Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
06 May

Berenberg Bank Sticks to Their Buy Rating for BioNTech SE (BNTX)

TIPRANKS
·
06 May

BioNTech Se : Citigroup Cuts Target Price to $140 From $145

THOMSON REUTERS
·
06 May

BioNTech price target lowered to $140 from $145 at Citi

TIPRANKS
·
06 May

BioNTech SE Reports Q1 2025 Financial Results

TIPRANKS
·
06 May

BioNTech SE ADR Sheds 3.7%, Underperforms Market

Dow Jones
·
06 May

BioNTech Appoints Novartis Executive As Finance Chief, Reaffirms 2025 Outlook Focusing on Oncology Expansion

Benzinga
·
06 May

BioNTech price target lowered to $127 from $143 at BofA

TIPRANKS
·
06 May

Sector Update: Health Care Stocks Lower Monday Afternoon

MT Newswires Live
·
06 May

Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), PTC Therapeutics (PTCT) and Larimar Therapeutics (LRMR)

TIPRANKS
·
06 May

Narrower Guidelines for Covid-19 Booster Wouldn't Limit BioNTech's Customer Base Much -- Market Talk

Dow Jones
·
05 May

European Equities Traded in the US as American Depositary Receipts Marginally Higher in Monday Trading

MT Newswires Live
·
05 May

Biontech SE reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
05 May

BioNTech Maintains Full-Year Revenue Outlook Despite Surprise Quarterly Sales Decline

MT Newswires
·
05 May

Novavax Updates Financial Terms With Takeda for Covid-19 Vaccine Agreement in Japan

MT Newswires Live
·
05 May

BioNTech Posts Wider 1Q Loss, to Focus on Oncology Programs

Dow Jones
·
05 May

BioNTech Reports Q1 2025 Financial Results and Strategic Oncology Advancements

TIPRANKS
·
05 May